The distribution of CDKN1B and CCND2 polymorphisms and susceptibility to CLL were studied in a group of 286 patients with previously untreated CLL recruited at the Clinical Department of Hematology, Cell Therapies and Internal Diseases, Wroclaw Medical University, Poland. Here, CDKN1B is linked to B-cell chronic lymphocytic leukemia.